Abstract Plants with hormonally active properties exert their effects through a diverse set of biochemical pathways, including direct steroid receptor modulation, enzyme inhibition, and neuroendocrine signaling. This preprint proposes a unifying framework categorizing phytochemical endocrine activity into six primary mechanisms: phytoestrogenic activity, 5α-reductase inhibition, aromatase inhibition, luteinizing hormone (LH) stimulation, prolactin modulation, and dopaminergic regulation. Building on this framework, three novel observations are presented: (1) monoamine oxidase B (MAO-B) inhibition as an endocrinologically relevant mechanism via modulation of dopaminergic tone; (2) the identification of certain botanicals as dual anti-estrogenic and anti-prolactinergic agents with downstream antiandrogenic reversal potential; and (3) the role of cortisol reduction and TRPV1 agonism as key drivers of LH upregulation. Together, these findings suggest a broader systems-level model of plant-derived endocrine modulation integrating central neurotransmitter dynamics with peripheral steroidogenesis. 1. Introduction Hormonally active plants have long been recognized in traditional medicine and increasingly studied in modern pharmacology. Most research has focused on isolated mechanisms—such as phytoestrogen binding or enzyme inhibition—without integrating these into a cohesive systems-level model. However, endocrine regulation is inherently multi-layered, involving feedback between the hypothalamic–pituitary–gonadal (HPG) axis, hypothalamic-pituitary-adrenal (HPA) axis, neurotransmitter systems, and peripheral metabolic enzymes. This work proposes a structured classification of plant endocrine activity and introduces additional mechanistic insights that extend beyond classical steroid-centric models. 2. Core Mechanistic Categories of Phytochemical Endocrine Activity 2.1 Phytoestrogens (+E)Phytoestrogens are plant-derived compounds that bind to estrogen receptors (ERα and ERβ), exerting agonistic or partial agonistic effects. Depending on context, they may produce net estrogenic or anti-estrogenic outcomes due to receptor competition and tissue selectivity. 2.2 5α-Reductase Inhibitors (−DHT)These compounds inhibit the conversion of testosterone to dihydrotestosterone (DHT), reducing androgenic signaling in tissues sensitive to DHT, such as prostate and skin. 2.3 Aromatase Inhibitors (−E)Aromatase inhibitors reduce the conversion of androgens to estrogens, thereby shifting the androgen–estrogen balance toward a more androgenic state. 2.4 LH-Stimulating Compounds (+LH)Certain phytochemicals enhance luteinizing hormone secretion, either through hypothalamic stimulation (GnRH release) or indirect modulation of upstream regulators such as cortisol and other neurotransmitters. 2.5 Prolactinergic Compounds (+PRL)These increase prolactin levels, typically via dopamine antagonism or suppression, and may suppress gonadal function through inhibition of GnRH. 2.6 Dopaminergic Compounds (−PRL)Dopamine agonists or enhancers reduce prolactin secretion by activating D2 receptors in the pituitary, thereby relieving prolactin-mediated suppression of the HPG axis. 3. Novel Mechanistic Insights 3.1 MAO-B Inhibition as an Endocrine ModulatorMonoamine oxidase B (MAO-B) plays a key role in dopamine metabolism. Inhibition of MAO-B increases synaptic and postsynaptic dopamine availability. Elevated dopaminergic tone leads to: Suppression of prolactin secretion via D2 receptor activation Disinhibition of GnRH release through reduced prolactin signaling Secondary increases in LH and downstream androgen production Thus, MAO-B inhibition should be considered an indirect but significant endocrine mechanism, particularly in the context of prolactin-sensitive hypogonadal states. 3.2 Dual Anti-Estrogenic and Anti-Prolactinergic Activity as an Antiandrogenic Reversal StrategyCertain botanicals appear to exert both anti-estrogenic (aromatase inhibition) and anti-prolactinergic (dopaminergic enhancement) effects simultaneously. This combination produces a synergistic endocrine shift: Reduced estrogenic negative feedback on the HPG axis Lower prolactin-mediated suppression of GnRH Enhanced LH secretion Restoration or amplification of androgen production This dual-action profile may represent one of the most potent plant-based strategies for reversing functional antiandrogenic states, especially those driven by elevated estrogen and prolactin. 3.3 Cortisol Reduction and TRPV1 Agonism as Drivers of LH Secretion Cortisol ReductionChronic elevation of cortisol suppresses GnRH and LH secretion. Phytochemicals that reduce cortisol—either via adaptogenic effects or direct modulation of the hypothalamic–pituitary–adrenal (HPA) axis—can relieve this suppression, leading to increased LH output. TRPV1 AgonismTransient receptor potential vanilloid 1 (TRPV1) activation has emerging relevance in neuroendocrine regulation. TRPV1 agonists may: Stimulate hypothalamic activity Enhance GnRH neuron firing Increase catecholamine tone Modulate endogenous opioid release Together, these effects may contribute to increased LH secretion. When combined with cortisol-lowering effects, TRPV1 activation may represent a key upstream trigger for reproductive axis activation. 4. Integrated Model of Phytochemical Endocrine Modulation The proposed framework emphasizes that plant endocrine activity is not limited to direct receptor binding or enzyme inhibition. Instead, it operates across three interconnected layers: Peripheral steroid metabolism (aromatase, 5α-reductase) Receptor-level modulation (estrogenic and dopaminergic signaling) Central neuroendocrine control (GnRH, LH, prolactin, cortisol) Mechanisms such as MAO-B inhibition and TRPV1 activation highlight the importance of central nervous system pathways in mediating systemic hormonal outcomes. 5. Implications and Future Directions This framework suggests several directions for further research: Quantitative assessment of MAO-B–mediated endocrine effects Identification of plant compounds with dual anti-estrogenic and dopaminergic activity Exploration of TRPV1 agonists in reproductive endocrinology Systems biology modeling of phytochemical interactions within the HPG and HPA axes Understanding these mechanisms may improve the development of plant-based therapeutics for hormonal imbalance, hypogonadism, and prolactin-related disorders. 6. Conclusion Hormonally active plants exert their effects through a complex interplay of enzymatic, receptor-mediated, and neuroendocrine mechanisms. Expanding the framework to include monoaminergic modulation, cortisol dynamics, and TRPV1 signaling provides a more comprehensive understanding of phytochemical endocrinology. These insights support a shift from reductionist models toward integrated, systems-level approaches in the study of plant-derived endocrine modulators.
Thomas Iff (Thu,) studied this question.